Status: current, Defined. Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4029072014 | Product containing belantamab mafodotin in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4029073016 | Belantamab mafodotin-containing product in parenteral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Belantamab mafodotin-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Some | ||
| Belantamab mafodotin-containing product in parenteral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Belantamab mafodotin-containing product in parenteral dose form | Is a | Product manufactured as parenteral dose form | true | Inferred relationship | Some | ||
| Belantamab mafodotin-containing product in parenteral dose form | Is a | Belantamab mafodotin-containing product | true | Inferred relationship | Some | ||
| Belantamab mafodotin-containing product in parenteral dose form | Has active ingredient | Belantamab mafodotin | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Belantamab mafodotin only product in parenteral dose form | Is a | True | Belantamab mafodotin-containing product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR